DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global leader in acute care, today announced the U.S. Food and Drug Administration (FDA) 510(k) clearance of the company’s ST ...

A new case report details the successful use of hemoadsorption alongside continuous renal replacement therapy (CRRT) to treat severe rhabdomyolysis caused by influenza B infection in a 14-year-old boy ...

Both the HF20 Set and ST Set are pre-connected disposable sets used with Baxter’s Prismaflex and PrisMax monitors, and work with all CRRT modalities and most commonly used anti-coagulants. The HF20 ...

Baxter was awarded FDA clearance for a device it won Emergency Use Authorization for during the beginning of the pandemic. The Deerfield, IL-based company said it has received a nod from FDA for the ...

Continuous and intermittent renal replacement therapies for patients with acute kidney injury (AKI) are associated with similar outcomes, data show. Robert L. Lins, MD, of Ziekenhuis Netwerk Antwerpen ...

Acute renal failure (ARF) can develop in critically ill patients as a result of multiple organ failure. Currently, a considerable proportion of surviving ARF patients are dependent on dialysis at ...